Zions Bancorporation’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-18,540
Closed -$883K 923
2024
Q2
$883K Sell
18,540
-617
-3% -$27K 0.07% 196
2024
Q1
$733K Buy
19,157
+1,723
+10% +$56K 0.05% 231
2023
Q4
$544K Buy
17,434
+474
+3% +$17K 0.04% 247
2023
Q3
$681K Buy
16,960
+7,338
+76% +$344K 0.06% 222
2023
Q2
$506K Buy
9,622
+105
+1% +$6.39K 0.04% 244
2023
Q1
$609K Buy
9,517
+2,091
+28% +$136K 0.05% 237
2022
Q4
$360K Buy
7,426
+339
+5% +$21.3K 0.03% 268
2022
Q3
$500K Sell
7,087
-15
-0.2% -$1.28K 0.05% 230
2022
Q2
$504K Buy
+7,102
New +$458K 0.05% 237

Other funds holding STAA

Zions Bancorporation's STAA Position: Q3 2024 in Review

Zions Bancorporation sold out of STAAR Surgical (STAA) in Q3 2024, closing a stake of 18,540 shares — an estimated $883K sold.

Zions Bancorporation first reported a position in STAA in Q2 2022 and held it in 9 quarters. The position peaked at $883K in Q2 2024. 236 funds tracked by Wall St. Rank hold STAA as of Q3 2024.

  • Zions Bancorporation reported no remaining STAAR Surgical position as of Q3 2024 after selling out during the quarter.
  • Zions Bancorporation sold 18,540 STAAR Surgical shares in Q3 2024, an estimated $883K.
  • Zions Bancorporation first reported a position in STAAR Surgical in Q2 2022 and held it in 9 quarters.
  • Zions Bancorporation's STAAR Surgical position peaked at $883K in Q2 2024.
  • 236 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2024.

Based on Zions Bancorporation's 13F filing for Q3 2024, filed 6 Nov 2024.